MeSH tree: B04.613.204.500.500.400
Primary sclerosis cholangitis, PSC in short, is a rare liver disease that destroys the bile ducts. It is a severe condition for which we currently have no effective treatments and often results in the patient requiring a ...
Jun 11, 2025
0
30
Many people are infected with the Epstein-Barr virus (EBV), and most are unaware of it. However, EBV can sometimes cause cancer, and this pathogen also appears to play an important role in multiple sclerosis and other autoimmune ...
May 19, 2025
0
36
Research into the most prevalent tumors in developing countries significantly lags behind research into those cancers that are more common in Western countries, resulting in higher mortality rates. One such example is Burkitt ...
May 16, 2025
0
34
A newly established team of researchers at Åbo Akademi University, led by Academy Research Fellow Silvia Gramolelli (Faculty of Science and Engineering), has discovered an additional function for Heat Shock Factor 2 (HSF2), ...
Apr 28, 2025
0
16
An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on Saturday won a prestigious Breakthrough Prize, the award nicknamed the "Oscars of science."
Apr 6, 2025
0
93
A recent study has revealed how Epstein-Barr virus (EBV) intensifies ulcerative colitis (UC), a debilitating inflammatory bowel disease. Researchers discovered that EBV infection triggers macrophage pyroptosis—a form of inflammatory ...
Mar 24, 2025
0
27
Olga Rivera Ballesteros from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is defending her thesis titled "Circulating and Resident Memory T cell functions in viral diseases" on 21 ...
Mar 17, 2025
0
11
MIS-C is a serious inflammatory shock that affects children. It can occur several weeks after a COVID infection and can be life-threatening. Until now, however, the precise cause of the condition was unknown.
Mar 12, 2025
0
100
In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and spinal cord. New research shows that the combination of certain viral antibodies and genetic risk ...
Mar 10, 2025
0
72
The Wistar Institute's Paul M. Lieberman, Ph.D. and lab identified and tested a new method for targeting certain cancers caused by Epstein-Barr Virus (EBV), in the paper, "USP7 inhibitors destabilize EBNA1 and suppress EBV ...
Mar 10, 2025
0
72
